{"DataElement":{"publicId":"5782160","version":"1","preferredName":"Chemotherapy Mercaptopurine Methotrexate Agent Not Taken As Prescribed Outcome Chemotherapy Agent Not Taken As Prescribed Outcome","preferredDefinition":"Information related to the outcome of not taking chemotherapy agents, Mercaptopurine or Methotrexate, as prescribed.","longName":"5782159v1.0:5782151v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"5782159","version":"1","preferredName":"Chemotherapy Mercaptopurine Methotrexate Agent Not Taken As Prescribed Outcome","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases._A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)_An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An operation in which a term denies or inverts the meaning of another term or construction._Having been accepted for some purpose; ingested as a medication._The result of an action._In the same amount or manner; to the same degree; in the role, function, or capacity of._Directions written for the preparation and adminstration of a drug.","longName":"5782078v1.0:5782157v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"5782078","version":"1","preferredName":"Chemotherapy Mercaptopurine Methotrexate Agent","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.:A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04):An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","longName":"C15632:C195:C642:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Mercaptopurine","conceptCode":"C195","definition":"A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Methotrexate","conceptCode":"C642","definition":"An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E11966F-A200-17A2-E053-F662850A1F89","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5782157","version":"1","preferredName":"Negation Taken As Drug Prescribing Outcome","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Having been accepted for some purpose; ingested as a medication.:In the same amount or manner; to the same degree; in the role, function, or capacity of.:Directions written for the preparation and adminstration of a drug.:The result of an action.","longName":"5782157v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Taken","conceptCode":"C25701","definition":"Having been accepted for some purpose; ingested as a medication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"As","conceptCode":"C64938","definition":"In the same amount or manner; to the same degree; in the role, function, or capacity of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Drug Prescribing","conceptCode":"C0033081","definition":"Directions written for the preparation and adminstration of a drug.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E13121F-6BEC-4637-E053-F662850A3E6C","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E13121F-6BFD-4637-E053-F662850A3E6C","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"MORENOC","dateModified":"2017-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5782151","version":"1","preferredName":"Chemotherapy Agent Not Taken As Prescribed Outcome","preferredDefinition":"The result of an action._The use of synthetic or naturally-occurring chemicals for the treatment of diseases._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An operation in which a term denies or inverts the meaning of another term or construction._Having been accepted for some purpose; ingested as a medication._In the same amount or manner; to the same degree; in the role, function, or capacity of._Directions written for the preparation and adminstration of a drug.","longName":"5782151v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"I would get an infection","valueDescription":"Acquisition Infection","ValueMeaning":{"publicId":"5782152","version":"1","preferredName":"Acquisition Infection","longName":"5782152","preferredDefinition":"The process by which something is acquired or obtained.: The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquisition","conceptCode":"C43384","definition":"The process by which something is acquired or obtained.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E127593-13BA-3D9A-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E127593-13D3-3D9A-E053-F662850ABE4D","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"My doctor would not be happy with me","valueDescription":"Doctor Feelings Sadness","ValueMeaning":{"publicId":"5782153","version":"1","preferredName":"Doctor Feelings Sadness","longName":"5782153","preferredDefinition":"A courtesy title for a person who has received a doctorate degree or who practices medicine.: Emotional sensations.: Feelings of grief or unhappiness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Doctor","conceptCode":"C69164","definition":"A courtesy title for a person who has received a doctorate degree or who practices medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Feelings","conceptCode":"C77965","definition":"Emotional sensations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sadness","conceptCode":"C74534","definition":"Feelings of grief or unhappiness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E127593-13E1-3D9A-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E127593-13FA-3D9A-E053-F662850ABE4D","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"My spouse/parent/significant other would be disappointed with me","valueDescription":"Spouse Parent Significant Other Frustration","ValueMeaning":{"publicId":"5782154","version":"1","preferredName":"Spouse Parent Significant Other Frustration","longName":"5782154","preferredDefinition":"A person's partner in marriage.: A mother or a father; an immediate progenitor.: A gender-neutral term for a person's partner in an intimate or romantic relationship without disclosing or presuming marital status or sexual orientation.: The motivational and/or affective state of annoyance resulting from being blocked, thwarted, disappointed or defeated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spouse","conceptCode":"C62649","definition":"A person's partner in marriage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Parent","conceptCode":"C42709","definition":"A mother or a father; an immediate progenitor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Significant Other","conceptCode":"C119265","definition":"A gender-neutral term for a person's partner in an intimate or romantic relationship without disclosing or presuming marital status or sexual orientation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Frustration","conceptCode":"C61483","definition":"The motivational and/or affective state of annoyance resulting from being blocked, thwarted, disappointed or defeated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E127593-1409-3D9A-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E127593-1422-3D9A-E053-F662850ABE4D","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"I would feel better","valueDescription":"Feelings Better","ValueMeaning":{"publicId":"5782155","version":"1","preferredName":"Feelings Better","longName":"5782155","preferredDefinition":"Emotional sensations.: In an improved condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Feelings","conceptCode":"C77965","definition":"Emotional sensations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Better","conceptCode":"C71685","definition":"In an improved condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E127593-142F-3D9A-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E127593-1448-3D9A-E053-F662850ABE4D","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"I might have a relapse/leukemia might come back","valueDescription":"Potential Relapse Leukemia Potential Recurrence","ValueMeaning":{"publicId":"5782156","version":"1","preferredName":"Potential Relapse Leukemia Potential Recurrence","longName":"5782156","preferredDefinition":"The likelihood or possibility that a specific state or condition will exist or that an action will occur.: The return of signs and symptoms of cancer after a period of improvement.: A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.: The likelihood or possibility that a specific state or condition will exist or that an action will occur.: To come back or to return.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Potential","conceptCode":"C62230","definition":"The likelihood or possibility that a specific state or condition will exist or that an action will occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Relapse","conceptCode":"C0699753","definition":"The return of signs and symptoms of cancer after a period of improvement.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"3"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Potential","conceptCode":"C62230","definition":"The likelihood or possibility that a specific state or condition will exist or that an action will occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrence","conceptCode":"C3352","definition":"Happening again (especially at regular intervals).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E127593-1458-3D9A-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E127593-1471-3D9A-E053-F662850ABE4D","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"I don't really know","valueDescription":"Does Not Know","ValueMeaning":{"publicId":"3247120","version":"1","preferredName":"Does Not Know","longName":"3247120","preferredDefinition":"The answer is not known by the person answering.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Does Not Know","conceptCode":"C67142","definition":"The answer is not known by the person answering.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6531898-A7F3-5C37-E040-BB89AD43329F","latestVersionIndicator":"Yes","beginDate":"2011-06-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E127593-1485-3D9A-E053-F662850ABE4D","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"None of the above","valueDescription":"None Above","ValueMeaning":{"publicId":"5293617","version":"1","preferredName":"None Above","longName":"5293617","preferredDefinition":"No person or thing, nobody, not any.: In a place or position that is higher.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Above","conceptCode":"C75329","definition":"In a place or position that is higher.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35538414-BF24-0F3D-E050-BB89AD43572F","latestVersionIndicator":"Yes","beginDate":"2016-06-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2016-06-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E127593-1490-3D9A-E053-F662850ABE4D","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E127593-149B-3D9A-E053-F662850ABE4D","beginDate":"2014-05-19","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5782150","version":"1","preferredName":"Chemotherapy Agent Negation Taken As Drug Prescribing Outcome","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.:An operation in which a term denies or inverts the meaning of another term or construction.:Having been accepted for some purpose; ingested as a medication.:In the same amount or manner; to the same degree; in the role, function, or capacity of.:Directions written for the preparation and adminstration of a drug.:The result of an action.","longName":"5782150v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Taken","conceptCode":"C25701","definition":"Having been accepted for some purpose; ingested as a medication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"As","conceptCode":"C64938","definition":"In the same amount or manner; to the same degree; in the role, function, or capacity of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Drug Prescribing","conceptCode":"C0033081","definition":"Directions written for the preparation and adminstration of a drug.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E127593-1390-3D9A-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E127593-13A1-3D9A-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"MORENOC","dateModified":"2017-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What do you think would happe","type":"Preferred Question Text","description":"What do you think would happen if you don't take your 6MP or Methotrexate as prescribed?","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E132897-3518-5C68-E053-F662850AFFA0","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"MORENOC","dateModified":"2017-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}